Supreme Petroch. (SPLPETRO)
CyclicalFairStock Score: 41/100 — MIXED
Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹726.55 |
| Market Cap | ₹13,662.14 Cr |
| P/E Ratio | 28.17 |
| ROCE | 22.76% |
| ROE | 12.68% |
| Dividend Yield | 1.45% |
| Profit Growth | 192.05% |
| Debt/Equity | 0.06 |
| Sales Growth | 22.01% |
| Free Cash Flow | ₹28 Cr |
| Promoter Holding | 64.24% |
| 52-Week Range | ₹462.3 — ₹899 |
| Sector | Chemicals & Petrochemicals |
| Book Value | ₹126.38 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
This business reminds me that a good company is not always a good investment. Supreme Petroch earns a ROCE of 22.76% and carries almost no debt—debt to equity of only 0.07. Promoters own 64.24%, so interests are aligned. But I cannot ignore the numbers. Sales have fallen 10.01%, profits are down 50.25%, and the latest quarter's net profit of ₹30 Cr on ₹1,265 Cr sales is a razor-thin margin. The 5-year revenue CAGR is just 2.41%; this is not a growth machine. At ₹820, I am asked to pay 49.64 times trailing earnings and 7.44 times book value for a cyclical petrochemical business in a downcycle. That is no margin of safety. The Piotroski F-score of 3/9 is a red flag—it tells me the company's financial health is deteriorating. Free cash flow of ₹28 Cr is tiny against a ₹13,479 Cr market cap. Yes, the balance sheet is conservative, and ROCE suggests decent capital allocation during good years. But a cyclical with declining earnings deserves a low multiple, not a high one. The market prices it near the top of its 52-week range, despite the profit collapse. The FairStock Score of 15/100 also flags risk. If I buy here, I depend entirely on a sharp cyclical recovery to justify the price. That is speculation, not investing. In Graham's language: no margin of safety, limited growth, cyclical vulnerability. I would wait for a better price or evidence of sustained margin recovery.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer